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Abstract 
Pig is one of the first animals that were domesticated, and pork is one of the most widespread 
meat products in food market. At present, up-to-date genetic and biotechnological approaches 
form a solid basis for the modern swine breeding methods. Key United States and European 
companies broadly use new genetic marker based methods for increasing productivity traits of 
their populations. 
The relevant worldwide patent information about genetic markers in swine breeding was 
collected during this project. All collected patent documents (145 documents in total and 84 
nonrecurring documents) were analyzed in a variety of ways. The present status of intellectual 
protection together with the last year’s and future trends were revealed. General suggestions 
about Norsvin’s research and intellectual protection strategy were done. 
Genotyping with markers of interest for a limited number of samples from Norsvin’s 
Landrace and Duroc pig populations was carried out in addition to the main line of the 
project. 
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1. Introduction 
1.1 Goals 
The main goal of this Master project was to collect relevant worldwide patent information 
about genetic markers in swine breeding and use this information for further evaluation of 
status of intellectual protection (IP status) for this field. The sub goal was to elucidate, in a 
general way, the potential influence of present IP status of marker assisted swine breeding on 
the Norsvin’s research and IP strategy.  
To achieve the main goal of the project it was necessary to: 1) choose types of patent 
documents for which search should be performed, 2) develop search strategy, and 3) make a 
decision about the way of storing, managing and analyzing the search results. 
Additionally it was decided to check with experimental work possible usefulness of some of 
the most relevant patented markers. 
1.2 The ways of achieving the goals 
Types of documents included in the search 
Patent search was performed within US, EPO and PCT patent documents. Search within these 
types of documents was preferred because almost all inventors worldwide typically try to get 
patents through at least one of these patent authorities (Bryant, 1998). Hence searches in these 
documents are the best way for revealing overall IP status of genetic markers in swine 
breeding.  
Search strategy 
Development of the searching strategy is the first and the most important part in a patent 
search. In a broad term search strategy is the planning of how to look for information. The 
search strategy should be performed before doing patent search. A well designed search 
strategy should allow search in many different public patent databases and help finding 
relevant information in a time saving manner (Hunt, Nguyen, & Rodgers, 2007). 
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Data storing, management and analyzing 
Because more than 100 patents were expected to be obtained during patent search, it was 
obvious that it was necessary to have some system to simplify organization, storing and 
retrieving these large amounts of data. A database was developed to achieve this.  
Usually simple databases that include just one table can be done using MS Excel electron 
tables. In fact MS Excel is not a database but it is something more technically known as a 
spreadsheet for maintaining the data on a limited scale (Fuller, 2007).  
It is more comfortable to work with electronic tables if the number of records is low. When 
number of data increases it is hard to manage them. Usually the reason for this is bad structure 
of the data. Also computer operation speed decreases with increasing number of data (Groh, 
2007).  
MS Access helps storing large amounts of data in one relational database and managing them 
using forms, queries and reports. This saves some computer memory, increases the data 
processing rate and helps to avoid mistakes and duplication (Lambert & Lambert, 2007). MS 
Access was therefore chosen for the data storing and managing. 
Experiments 
The decision was made to carry out genotyping with markers of interest for a limited number 
of samples from Norsvin’s Landrace and Duroc pig populations, to determine if the markers 
are segregating in the populations or not and whether they are in the Hardy-Weinberg 
equilibrium (HWE). Although presence of polymorphisms for some claimed markers and 
knowledge about their HWE are not straight forward indication of the markers’ utility 
obtaining this information is clarifying potential usefulness of these markers in future 
association studies. 
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2. Background 
2.1 Genetic markers in swine breeding 
Pig is one of the first animals that were domesticated, and pork is one of the most widespread 
meat products in food market. At present, up-to-date genetic and biotechnological approaches 
form a solid basis for the modern swine breeding methods. 
Although the traditional methods of selection are generally recognized, and has been effective 
during a long period of time, it is now obvious that using just these methods cannot provide 
proper efficiency level of breeding work (Rothschild, Stalde, & Dekkers, 2010). 
It is very simple to select animals for Mendelian inherited traits (examples of Mendelian 
inheritance include autosomal dominant, autosomal recessive, and sex-linked genes) using 
traditional methods of selection (Lambe & Simm, 2004). In contrast, selection of organisms 
which bear some advantageous quantitative traits (traits that are controlled by multiple genes 
and highly influenced by environment) is a very hard task. This selection typically should be 
carried out for generations. Marker-assisted selection (MAS) provides a great opportunity for 
accelerating this procedure (Dekkers, 2004). MAS is a process whereby a genetic marker is 
used for indirect selection of a trait of interest. 
Broadly speaking, a genetic marker is a nucleotide sequence variation which location is 
precisely defined on the chromosome or on the part of the chromosome (Navajas & Simm, 
2004). Genetic markers appear in result of different types of DNA mutations: substitution 
mutations (point mutations/Single Nucleotide Polymorphisms (SNPs)), rearrangements 
(insertions or deletions) and errors in replication of tandem repeated DNA (Beuzen, Stear, & 
Chang, 2000).  
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Genetic markers are usually located within the non-coding regions of the chromosomes and 
they are therefore usually not directly affecting the traits and consequently often selectively 
neutral (Beuzen, Stear, & Chang, 2000). However, the vast majority of genetic markers are 
placed in the close proximity to the genes that provide development of some traits and can be 
used like “tags” for these genes. Even if genetic markers are located within a gene they 
generally do not have any straight influence on the gene’s function, they are just linked with 
some features that provide this function and can be utilized like “tags” for allelic variations of 
a gene (Beuzen, Stear, & Chang, 2000). 
Genetic markers can be classified in variety of ways. First, they can be classified according to 
the methods of detection, like restriction fragment length polymorphism (RFLP) or 
polymerase chain reaction restriction fragment length polymorphism (PCR-RFL) markers, 
random amplified polymorphic DNA (RAPD) markers, amplified fragment length 
polymorphism (AFLP) markers and so on. Second, they can be classified according to their 
origin into simple sequence repeats (SSRs) or “microsatellites” markers, SNP markers and so 
on. Third, genetic markers can be divided into dominant and co-dominant markers. This 
division is based on number of forms (so called marker alleles) in which the marker can be 
detected. Dominant markers can be either present or absent (i.e. can study only one out of 
minimum two alleles) whereas for co-dominant markers entire allelic variations of their locus 
can be distinguished (i.e. can study two or more alleles for each locus). 
Identification of genes, which allelic variances change predisposition of an organism to have 
some trait of interest is a great tool that allows evaluating genetic profiles of organisms and 
using these profiles for further breeding purposes. That is why key US and European 
companies broadly use new genetic marker based methods for increasing productivity traits of 
their populations. 
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2.2 Patents 
2.2.1 General information about patents 
A patent is a government-granted monopoly on an invention to an inventor or their assignee 
for a limited period of time in exchange for a public disclosure of an invention (U.S. 
Department of Commerce, 2008). The term “limited period of time”, means the maximum 
period of time where a patent can be maintained into force. It is usually expressed in number 
of years (typically up to twenty years) either starting from the filing date of the patent 
application or from the date of grant of the patent (Engelfriet, Frequently Asked Questions: 
General questions, 2002). As long as the patent is valid the owner has to pay a yearly fee in 
order to keep the patent in force. Otherwise the patent will be lapsed before its term (U.S. 
Department of Commerce, 2008). 
The scope of a patent is information about what the patent exactly is protecting. By rule all 
this information should be included in a patent’s claims (Rothschild & Newman, 2002). All 
patent’s claims are organized in a single set and a lot of standard sets of claims can be found 
in the patent literature (Bryant, 1998). The terms which are used in the claims can be defined 
during the whole patent document. These arbitrary defining terms can significantly broaden 
the scope of a patent (its literal wording) (U.S. Department of Commerce, 2008). 
Claims are used to define the validity of a patent by comparing them against the prior art and 
to make a decision about infringement of exclusive rights which is given through the patent 
protection. To infringe the patent, infringing product must contain each and every element of 
claims (Engelfriet, 2005). As soon as inventors try to cover as much as possible by their 
patent, in each field of technology specific for this field broadening languages were 
developed. These languages allow broadening out the scope of the patent beyond its literal 
wording (Cambia). 
Patents are exclusively national affairs, so a patent that was issued in one country cannot 
provide protection of the invention in any other countries in the world. However, some 
countries have concluded treaties under which patents can be granted, and these patents 
automatically become valid in all treaty members (Engelfriet, Frequently Asked Questions: 
General questions, 2002). 
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2.2.2 Main categories of patents 
International applications 
International applications are the patent applications that are filed under the Patent 
Cooperation Treaty (PCT) which was administered by World Intellectual Property 
Organization (WIPO) (Patent Cooperation Treaty, 1970). 
Two things should be noted about international applications. First of all, these applications do 
not give any international protection to the applicant. The applicants are free to file whatever 
they wants, so it can easily happen that the applicants file something that is useless, long 
known or totally trivial (Engelfriet, Frequently Asked Questions: General questions, 2002). 
Second, WIPO does not get any responsibility for the issuing patents in any of the PCT 
countries. It just offers a way to file one application centrally. The applicants then have to 
enter national phase (foreign filings) of the countries of their choice within the time limits to 
do so and defend their claims to get a patent in those national offices. That is why PCT 
applications unlike most patent applications can never result in a patent (Rothschild & 
Newman, 2002). 
However, many inventors all over the world try to get this type of application at the 
beginning, because PCT applications provide several benefits to applicants. First, it allows the 
applicant to delay the expenses of filing applications around the world. Second, just one 
literature search will be performed and all national patent offices indicated on the front page 
of the publication will use results of this search for document examination. Third, by filing a 
PCT application, the applicants can postpone the decision on patenting their invention for 30 
months (rather than 12 months under the Paris Convention) in the others PCT countries. It 
allows the inventors more time to assess the commercial viability of their invention (Bryant, 
1998). 
  
 16 
European patents and applications 
The term European patent is used to refer to patents granted under the European Patent 
Convention (EPC) (European Patent Convention, 1973). 
Two ways may be appropriate for getting a European patent. First of all, the inventor can file 
patent application directly with the country, or countries, in the European Union (EU) in 
which patents are desired. Second, the inventor can do single filing of a patent application 
with the European Patent Office (EPO) (Bryant, 1998). 
EPO is the official organization which actual legislative power proceeds from EPC. The EPO 
is not a body of the EU and patent granted by the EPO does not lead to a single EU-wide 
patent (Rothschild & Newman, 2002). However, the EPO offers a way to file a single patent 
application which can lead to patent coverage in all the European countries that belong to the 
EPC. In fact EPO patents get a legislation power through independent national patents in the 
EPC countries of choice (Durham, 2004). 
Usually if the inventor wants to get a patent only in one or two countries of Europe, it may be 
cheaper to apply directly into national offices of these countries. On the other hand, if the 
patent is planned to cover all or the biggest part of the EPC countries, then it will be 
favourable to file directly with the EPO (Rothschild & Newman, 2002). 
United States patents and applications 
United States (US) patents and applications can be defined as patents and applications granted 
under the US patent law. The provisions of the law are laid out in Title 35 of the US Code 
(U.S. Code Title 35) and give authority for the US Patent and Trademark Office (USPTO) 
(U.S. Department of Commerce, 2008). 
US patents give a monopoly right in the whole territory of the US. According to this nobody 
but the patent holder can make, use or sell the invention in the US (Bryant, 1998). Because 
the US is a huge market and US patenting system is one of the oldest systems in the world, all 
inventors are typically trying to get a US patent even if they have other patents all over the 
world. 
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2.3 Patenting of genetic inventions 
2.3.1 Patentability 
In principle all genetic inventions fall into the category of biotechnological inventions. These 
include inventions which are biological, microbiological, genetic engineering, medical, and 
agriculture (Lakshmikumaran, 2007). Article 27(1) of the Agreement on Trade-Related 
Aspects of Intellectual Property Rights (TRIPS Agreement) clearly states that patents should 
be granted for inventions in any field of technology without discrimination, subject to certain 
clauses (TRIPS Agreement, 1994). This implies that biotechnological inventions and 
consequently all genetic inventions are patentable subject matter. 
The US Courts and EPO have granted patents to genetic inventions. However, the issue of 
patentability of genes and gene sequences is yet not clear (Jauhar & Narnaulia, 2010). In the 
EPC Countries the issue can be clarified using Rule 27 of the EPC (Patentable 
biotechnological inventions). This rule states that all DNA sequences and isolated genes are 
patentable subject matters as soon as they were isolated from its natural environment and 
characterized at the same way like chemical compounds (European Patent Convention, 1973). 
However, at the present stage this rule is narrowed by Biotechnology Directive (98/44/EC). 
After this directive had been settled it became impossible to get a patent on DNA sequence or 
isolated gene without any characterization of its function or/and without any idea of its use 
(Biotechnology Directive, 1998).  
In practice the US law is very similar to the European law in the definition of what should be 
patentable within the area of genetic inventions. While the USPTO often makes the 
determination as to whether an invention is patentable or not, the standard is actually set by 
the Courts and is only exercised by the USPTO. The Courts can overrule the USPTO in 
litigation (U.S. Department of Commerce, 2008). Using the experience of previous US court 
cases on DNA patents it can be concluded that it is improbable that the US patent law will 
favour the objection that isolated genes must be categorized as unpatentable discoveries if its 
actual use was evident or studied by the inventor (Crespi, 2000). 
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In summary, it can be concluded that to get a DNA patent in US or Europe, broadly speaking, 
inventors must isolate and identify novel genetic sequences, specify the products of these 
sequences and specify how these products functions in nature (i.e. its use) (Crespi, 2000). 
However, some more specific questions related to this field can still occur and should be 
clarified. Some of these questions are answered below. 
2.3.2 General questions 
Can different inventors patent the same DNA strands? 
Yes they can. Sometimes, different inventors can get a patent on the same DNA strands 
simply because the strands were discovered using different methods. Also, the methods 
themselves can be patented (John, 1998). 
How will the issuance of a patent on DNA fragments of a gene affect the patenting of 
full-length genes? 
Patent claims limited in scope to specific novel and non-obvious DNA fragments, for example 
SNPs or expressed sequence tags (ESTs), will not necessarily prevent the future patenting of 
the corresponding full-length gene of known function, if significant amount of information 
about the gene and/or protein (which can be the product of a gene) will be disclosed in 
another patent application (John, 1998). 
Can patent be granted on something within a patented sequence/gene? 
If the patent on the invention is granted, this patent covers all possible uses of this invention. 
It means that nobody can use claimed invention in any ways, even if these ways was not 
mentioned in the claims, without infringing the patent (Engelfriet, 2002). However, method of 
using the claimed invention may be patentable itself, assuming that this method is non-
obvious. In this situation the first patent (on the invention) will dominate over the second 
patent (on the new method of use), because for practicing the second patent it will be 
necessary to obtain license on the first one (Rothschild & Newman, 2002). Moreover in some 
cases fees have to be paid just for examining the claimed sequence or having the ability to 
invent something new within the sequence that was already claimed. Sometimes the situation 
can become really complicated when a researcher have to purchase 3-8 licenses at once as a 
result of allowing multiple patents on different parts of the same genome sequence (John, 
1998). 
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Genetic Testing – Infringement? 
This question is two parts: 
1. If a laboratory works with the patented isolated genetic sequence, will it infringe the 
patent?  
2. If a laboratory works using the patented method of diagnosis, will it infringe the 
patent? 
There are two possible answers, depending on the examination of the actual granted patent 
claims. First of all, there may be opportunities for inventing around the patent. It is usually 
permitted when the patent is old and new laboratory or diagnostic methods have been 
developed (new sequencing technologies, for example) (Hawkins, 2010). Second, if a valid 
gene patent exists, and infringing can be proved, inventor can use some legal defenses. The 
most relevant defense for the purpose of gene patents and diagnostic testing is the 
experimental use defence. Researches that aim either to verify claimed functions or to 
determine new functions of a patented gene sequence, to find new genetic markers within a 
patented gene sequence, to find new information related to a gene sequence and to develop a 
new genetic diagnostic test will most probably be covered by the experimental use defence 
(Hawkins, 2010). However it is very important to note that the research tools which has been 
validated and becomes routine at the time when researcher perform it (like Polymerase Chain 
Reaction (PCR)) will not be an act done for experimental purposes relating to the subject 
matter and will not fall within the research exception (Hawkins, 2010). 
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2.4 Survey of MS Access database management system 
2.4.1 General information about data storage and managing 
2.4.1.1 Relational data model 
A data model is an abstract model which explains the way of data storing and access. There 
are many possible data models that can be applied for the databases construction. For 
example: 
 Flat file model - data is organized into two-dimensional array of data elements. 
 Hierarchical model - data is organized into a tree-like structure.  
 Network model - data is organized into network-like structure, which is not restricted 
to be a hierarchy or lattice. 
 Relation model - data is organized using concept of objects and relations between 
object. 
Today almost all databases (including MS Access) correspond to the relational data model 
(Groh, 2007). A database that is constructed using relations is called relation database. This 
type of database is described in detail below. 
Two-dimensional tables are one of the most natural ways of data representation. Data about 
different types of objects (object’s attributes) is stored inside the different tables in the form of 
columns and rows and one complete set of data for one object is called a record (Fuller, 
2007). 
Relation between objects can also be represented in the flat table (Lambert & Lambert, 2007). 
For instance relation between two tables (i.e. two objects) can be settled by a third table which 
should store identification number (ID) of records from the first table and ID of records from 
the second table in the first column and in the second column, respectively (Figure 1). 
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It can be three types of relations between tables: one-to-one – one record from table 1 is 
linked with just one record from table 2; one-to-many – one record from table 1 is linked with 
many records from table 2; many-to-many – many records from table 1 are linked with many 
records from table 2. In the case of one-to-many relation, table “one” is called main table and 
table “many” is called slave table (Lambert & Lambert, 2007).  
It should be noted that each table of the relational database can be defined like relation, 
because inside each table, attributes of each record (i.e. intercrosses between record’s row and 
columns) are linked together in the one-by-one manner (Groh, 2007). In the case of the 
relation database terms “relation” and “table” can be used like synonymous. 
Hence all data can be stored and represented using flat tables (Lambert & Lambert, 2007). 
Each row of each table consists of data about one object. Row is typically named like records 
and columns like fields of the record. Fields consist of attributes of the record’s objects. All 
records have identical fields, which include different values of attributes. Each field has a 
strictly defined data type (text, number, date and so on) (Jennings, 2007).  
Fields which form a unique 
identifier in a one-to-one 
correspondence manner for each 
database record are called key fields 
(the same with ID). Key fields are 
used like a table entry to link tables 
together and help to perform fast 
search of data for further 
representation in the form of 
queries, forms and reports (Groh, 
2007). 
  Figure 1. Relational model concepts 
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2.4.1.2 Database management system 
It should be noted that the term database includes just a subset of the tables. All the rest, like 
storage and maintenance of database’s content and data creation and search belong to the 
database management system (Groh, 2007). Database management system is the specialized 
program package that is used for working with the data. 
The most important function of the database management system is to provide database 
integrity. It means setting some rules on the relations between tables: It should be impossible 
to put attribute that do not exist in the main table into the fields of a slave table; It should be 
impossible to delete attributes from the main table if there are existing links to the records in 
the slave tables; It should be impossible to change key fields in the main table if there are 
existing links to the records in the slave tables (Lambert & Lambert, 2007). 
All operations with the data typically require using special Structured Query Language (SQL). 
The main advantage of MS Access database management system is that the main operation 
with data can be done using visual construction method of queries to the database (Lambert & 
Lambert, 2007). In this situation SQL query is automatically generated by MS Access.  
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2.4.2 Main elements of MS Access database management system  
Tables 
Tables are the main part of each relational database. First, all data within the database are 
stored inside the tables. Second, tables are storing database structure (fields and their types 
and properties) (Groh, 2007). 
Queries 
Queries are used for extracting data from the tables and representing them in a user friendly 
manner. All operations of data searching, selection, sorting and filtration are done using 
queries. Queries allows to do changes in the data using a given algorithm, creating new tables, 
doing automatically fill up of the tables, importing data from other sources, doing main 
calculation inside tables and so on (Groh, 2007). 
Forms 
If queries are specialized tools for data selection and analysis, forms are the tools for data 
input. Forms have the same idea, allowing the users to fill up just fields that they should fill 
up. For this purpose special control elements (buttons, checkboxes and so on) can be located 
on a form which provides more comfortable input and navigation (Groh, 2007). 
Reports 
In the term of structure and properties reports are very similar to forms, but their purpose is 
just to represent data, typically in the printed format. Hence reports have special features for 
data sorting, grouping and data representation design (Groh, 2007). 
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2.5 Patent search 
2.5.1 Introduction to the search strategy development 
2.5.1.1 Main information 
For finding relevant information it is really important to get a focus on what has been 
previously claimed or could be potentially claimed in the area of interest. Think about what 
should be found by concentrating upon the idea of the inventions. In other words, to find 
relevant information it is necessary to have the key concepts of a search (Miller, 1999).  
Key concept is the written equivalent of the idea of the invention. Key concept should be 
written down in a form of an affirmative sentence using ordinary writing language (Calishain, 
2004). This sentence will be further braced into key terms (keywords and key phrases) which 
should be used for generating queries to the online patent databases (Figure 2). Number of 
key terms can be raised by using synonyms, spelling variations and so on (Baylin & Gill, 
2005). 
Queries to the online patent databases are preferably formed from keywords and key phrases 
using Boolean operators. A query can be broadened by using OR operator instead of AND 
operator for joining terms together, using more general search terms and using truncations 
(Calishain, 2004). 
When a query is constructed, the searcher can go to the on-line patent storages to perform 
preliminary patent search. Performing search in the right places is the main requirement for 
the success (Hunt, Nguyen, & Rodgers, 2007). For 
finding a good place of patent search the searcher 
should ask himself the following questions: Are 
there some places that collect patents, which 
directly relate to my searching field? How 
comprehensive is the patent collection in this place 
of search? How much searching facilities are 
available if I perform a search at this place? And, 
how user friendly is search results’ representation 
in this place of search? 
Figure 2. Idea of key concepts 
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After preliminary search have been performed, it can be useful to do some adjustments to the 
search strategy. This first feedback can help to refine queries, to find new searching criteria 
and to organize the search into one strain line in the most comfortable and time saving manner 
(Hunt, Nguyen, & Rodgers, 2007). 
2.5.1.2 Using patent classification for finding additional search 
criteria 
Patent classification is a system for organizing patents by subject matter. Main purpose of this 
system is to facilitate patents retrieval by manual patent searches. Two main patent 
classification systems: United States Patent Classification (USPC) and International Patent 
Classification (IPC) are described in details below. 
The USPC is an official patent classification system used and maintained by the USPTO. It 
contains over 400 classes. Each class is identified by a class number and have a title that 
describes its subject matter. Each class is subdivided into a number of subclasses. Each 
subclass also has a subclass number and descriptive title. The subclass number may be an 
integral number or may contain a decimal portion and/or alpha characters. A complete 
identification of a subclass requires both the class and subclass number and any alpha or 
decimal designations; e.g., 435/6 identifies Class 435, Subclass 6 (Figure 3) (Hunt, Nguyen, 
& Rodgers, 2007). 
The IPC is a hierarchical patent classification system created under the Strasbourg Agreement 
(Strasbourg Agreement, 1971). The Strasbourg 
Agreement is one of a number of treaties 
administered by the WIPO. Each classification 
term consists of a symbol such as C12Q 1/68. 
The first letter is the "section symbol". This is 
followed by a two digit number to give a "class 
symbol". The final letter makes up the 
"subclass". The subclass is then followed by a 1 
to 3 digit "group" number, an oblique stroke 
and a number of at least two digits representing 
a "main group" or "subgroup" (Figure 3) (Hunt, 
Nguyen, & Rodgers, 2007).  
Figure 3. Patent classifications 
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IPC is used by almost all patent authority all over the world. However, vast amount of patents 
that were issued in the US had not been satisfactory classified according to IPC. The reason 
for this is, first of all, that US patent examiners classify patents with US marks more 
accurately than they do with IPC marks and secondly, this classification was established 100 
years later than UPC (Hunt, Nguyen, & Rodgers, 2007).  
2.5.2 Searching public databases 
2.5.2.1 Types of databases 
There are two types of patent databases that should be pointed out: primary patent databases 
and secondary patent databases. Primary patent databases are storages of data deriving 
directly from issuing patent authority. By definition these databases contain all information 
about all issuing patents (Baylin & Gill, 2005). Secondary patent databases are storages of 
data that was extracted from primary patent databases and organized in a different way 
(Baylin & Gill, 2005). Secondary patent databases are usually incorporated into a search 
engine (Figure 4). 
Search engine is a suite of programs which contain: “Spider” - program that upload Web-
pages from the Internet into a search engine; “Crawler” - program that go through uploaded 
Web-pages and search for a links to 
other Web-pages, thereby giving 
direction of further movement to the 
Spider; “Indexer” - program that 
divide Web-page into distinct parts 
and index this parts; “Database” - 
program that store all indexed data; 
“Result engine” - program that 
analyze query from user, perform a 
search in the incorporated database 
and return results that can be 
relevant to the query (Figure 4) 
(Calishain, 2004).  
  
Figure 4. Primary and secondary database 
concepts 
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In a simple term the work of search engine can be described as follows: Search robot (Spider 
plus Crawler) go through all relevant web-sites and upload all relevant web-pages from these 
web-sites into the search engine. Inside the search engine web-pages are indexed and saved in 
an incorporated database by indexer. After the user puts a query into the result engine, this 
program analyzes it and returns results from an incorporated database that possibly solve the 
query. Therefore the user works only with one part of the search engine, namely, the result 
engine and can get the results from search engine incorporated database only. So results can 
be not comprehensive since they were already filtered by search robot (Miller, 1999). 
Primary patent databases are also incorporated into a specific suite of programs, but in 
contrast with the search engine this suite contains just the result engine and the database 
themselves. All data are indexed by hands or auto-manual. These databases contain all patents 
that relate to their field and all comprehensive information about each patent (Figure 4) 
(Calishain, 2004). 
Both primary and secondary databases have their own pros and cons. Secondary databases 
usually have more user friendly search interface, collect specific information about one field 
from many primary databases and allow doing worldwide search. However, no secondary 
databases can give a guaranty that they contain all patents that was issued by patent 
authorities. Only primary databases can give this guaranty (Hunt, Nguyen, & Rodgers, 2007). 
2.5.2.2 Types of search 
By types of search means types and formats of queries that are acceptable for the result 
engine. All result engines are using specific internal languages. Basically these languages 
have specific syntactical rules for distinguishing key words from key phrases, for combining 
key terms together and for distinguishing filed within patent document where user suppose to 
perform a search using each of the key terms. 
Usually the result engines accept several types of query input (Miller, 1999). The user can 
either type query directly on internal language or use adopting interactive forms, information 
from which will be further automatically analyzed and rewritten on internal language by the 
result engine. 
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All searches can be classified according to the number of fields within a patent document 
where the user wants to perform search into simple search (just one field) and advanced 
search (many fields), and according to the format of query input into Boolean search (using 
internal language) and structural search (using interactive forms) (Hunt, Nguyen, & Rodgers, 
2007). 
Typically all patents web-sites allow the user to do simple structural search (often called just 
simple search or quick search), advanced Boolean search (often called Boolean search) and 
advanced structural search (often called either structural search or advanced search). 
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3. Materials and methods 
3.1 Patent-oriented MS Access database construction 
In the MS Access, like in the other types of database management systems, data structure 
should be constructed before actually starting database creation. Therefore, initial phase of the 
database construction should be done on a paper and thereafter tables, forms and other 
elements can be done using the program. Good data structure is the main requirement for 
creation of effective and user friendly databases. It should be noted that during database 
testing more and more adjustments are typically required and if data structure was done well it 
is not a problem to change database without starting from scratch.  
Database construction was done in four stages: 
1. The main information that should be stored and the way this information should be 
managed were defined. In other words, the purpose of the database was specified. 
2. General list of fields that should be relevant to the database purpose was created. At 
the start it was 24 fields which then were filtered during database improvement. 
3. All fields were combined into groups using functional criterion. It was done in the 
form of entity-relationship model (ERM). Entity-relationship modelling is a database 
modelling method used to produce a type of conceptual diagram of a system (entity-
relationship diagram, ER diagram, or ERD). In a form of ERD system is described 
using linked blocks, which represent entities (objects), entity's attributes and relations 
between entities (Groh, 2007). 
4. Relational data model and database elements were created using MS Access Database 
management system. 
First stage was already discussed in the Introduction part and will not be described below. 
Complete list of fields (after filtering) is presented in Table 1 and Table 2. ERM of the patent-
oriented database is depicted in Figure 5. Results from final (fourth) stage are presented in the 
Results section. 
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Table 1. List of fields for the patent-oriented database 
Item Description 
B
ib
lio
gr
ap
h
ic
al
 
 d
at
a 
 
Patent/Application Number 
This item includes: 
 US Patent number 
 US Application Document number 
 WIPO Publication number 
 EP Publication number 
Type of the Document 
This item includes: 
 International application 
 European patent/application 
 US patent/application 
Title of the invention 
This items include standard bibliographical data from 
the front page of a patent 
Date of Issue 
Language of the Document 
Primary Inventor 
Abstract 
Claims 
Primary USPC 
class/subclass 
Primary IPC class/subclass 
Organizations 
This item includes all organizations (Companies, 
Universities, National Departments and so on) that 
mentioned on a front page of a Patent (i.e. Applicants 
for the International application, Assignees for the US 
patent/application) 
Links to the proper Public 
Databases 
This items include links to the public patents databases 
Also published  as 
This item includes references to the similar 
patents/applications from other patents authorities 
 
  
 31 
Table 2. List of fields for the patent-oriented database (continue) 
Item Description 
A
d
d
it
io
n
al
 
d
at
a 
 
Internal Database Number 
This item includes number of unique document in 
Internal MS Access database (since some  
patents/applications from different patent authorities 
can have the same content they should be grouped 
together with a single document’s number) 
Internal Data Base 
classification 
This item includes: 
 Exterior 
 Health 
 Meat Quality 
 Production 
 Reproduction 
Status in Norway 
This item includes: 
 The same patent is granted 
 The same patent can be granted 
 Not granted or cannot be granted 
 Granted 
 Can be granted 
Breeds 
This item includes all breeds that where mentioned in 
Example/Experimental part of a patent/application. 
Type of Marker 
This item includes information about types of markers 
that were mentioned in the example/experimental part 
of a patent/application. However it does not mean that 
other types of markers were not covered by that 
patent/application (In the patent/application can be 
noticed that other markers can be suitable for the same 
genotyping).  
Genes 
This item includes information about genes that was 
mentioned in the patent, including their name and 
common abbreviation.  
 
 Figure 5. Entity-relationship diagram of the patent-oriented database 
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3.2 Patent search 
As was already mentioned search strategy development should include eight stages: 
 Figure out the main focus of a search using information that is already known and 
better judgments about information that should be found. 
 Identifying and defining the key concept of a search.  
 Extracting key terms. 
 Finding alternative key terms: synonyms (boar – pig), spelling variations, variations of 
a root word (pig – piglet), plural/singular forms (marker – markers), acronyms (ESR 
gene – Estrogen receptor gene). 
 Generating queries and performing preliminary patent search using proper public 
databases. 
 Refining the preliminary search. 
 Analyzing results of preliminary search. Finding additional search criteria.  
 Final patent search. 
Realization of these stages is presented below. 
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3.2.1 Identifying and defining key concepts and terms 
To define the main focus and the key search concepts, all relevant patents (20 patents) found 
by previous searchers were examined. General queries (key concepts) were constructed, using 
information from this examination. 
General queries: 
 Porcine polymorphisms and methods for detecting them 
 Marker assisted swine breeding 
 Approaches to identify genetic traits in animals 
 Genetic marker based pig selection 
Then general queries were broken down into its key terms and alternative terms were found. 
All key terms fell into three groups (Table 3): 
 Main field – this group include key terms that relate to the main field of a search. 
 Species – this group include key terms that relate to the species of interest. 
 Traits – this group include key terms that relate to the traits of interest. 
Table 3. Key terms (key phrases in the quotation marks can be divided into key 
words) 
Main field Species Traits 
 gene/genes 
 QTL/QTLs 
 “genetic 
polymorphism/polymorphisms” 
 “genetic marker/markers” 
 “molecular marker/markers” 
 “DNA 
polymorphism/polymorphisms” 
 “DNA marker/markers” 
 “marker assistant selection” 
 “marker assistant breeding” 
 pig/pigs 
 piglet/piglets 
 swine 
 boar/boars 
 porcine 
 pork 
 sow/sows 
 fatness 
 “animal growth” 
 “meat quality” 
 “feed efficiency” 
 “reproductive efficiency” 
 “disease resistance” 
 “carcass traits” 
 “litter size”  
 “boar taint” 
 “weight gain” 
 “muscle growth” 
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3.2.2 Survey of publicly available databases used during patent 
search 
3.2.2.1 General information about databases 
United States patents and applications 
USPTO Full-Text and Image Database 
Main information: It is the official site of the USPTO. The database is normally updated every 
Tuesday. 
Searchable documents: Front page data (with revised USPC), text of claims and description of 
US patents from 1976 are available. Images of patents from 1790 are available. Published 
applications from 15 March 2001 are available as a separate database in the same way as 
grants (the “assignees” are often not given). Issued and Published Sequences are available as a 
separate database. Revised versions of patents following litigation and correction slips are not 
included. 
Search facilities: quick search, advanced Boolean search and number search are available for 
both patents and applications. Published sequences are searchable by document number and 
date range.  
Google Patents Search 
Main information: It is a search engine from Google that index patents and patent applications 
from the USPTO. 
Searchable documents: Approximately 7 million full-text US patents and over a million US 
patent applications are available. 
Search facilities: quick search, advanced Boolean search and advanced structural search are 
available. 
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DNA Patent Database (DPD) 
Main information: It is a Search engine that index DNA-based patents and patent applications 
from the USPTO. The database is normally updated weekly. 
Searchable documents: Over 57,000 links to the DNA-based patents issued from 1971 to the 
present and over 89,000 links to the DNA-based patent applications published from 2001 to 
the present. 
Search facilities: quick search, advanced Boolean search and advanced structural search are 
available. 
World wide search 
PatentScope 
Description: It is the official site of the PCT. It is updated each Thursday. 
Searchable documents: Contains around 1.8 million published International Patent 
Applications and the collections of patents from some national phases. 
Search facilities: quick search, advanced Boolean search and advanced structural search are 
available. 
Esp@cenet 
Description: This is the EPO gateway. The database is normally updated weekly. 
Searchable documents: Contains granted European Patent which indicated by a “B” document 
kind code and European published applications which indicated by an “A” document kind 
code. The “worldwide” format enables searching across a vast amount of national phases data. 
Search facilities: quick search and advanced structural search are available. 
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Patent Lens 
Description: It is a Search engine that index patents and patent applications from PCT, 
USPTO, EPO and Australian Patent Office (AU). The database is normally updated weekly. 
Searchable documents: Contains full-text of over 8 million patents and applications from 
PCT, USPTO, EPO and AU with list of issued and published sequences. 
Search facilities: quick search, advanced Boolean search and advanced structural search are 
available. 
3.2.2.2 Databases comparison  
Brief database comparison is showed in the table bellow (Table 4). 
 
Table 4. Database comparison 
 
United States patents and applications World wide search 
USPTO Full-
Text and 
Image 
Database 
Google 
Patents 
Search 
DNA Patent 
Database 
(DPD) 
PatentScope Esp@cenet Patent Lens 
Type of database Primary Secondary Secondary 
Primary just 
for IPA 
Primary just 
for EP 
Secondary 
Full-text documents Yes Yeas 
No just 
links to 
USPTO 
Yes Yes Yes 
Sequences search Yes No No No No Yes 
Search 
facilities 
Simple 
search 
Yes Yes Yes Yes Yes Yes 
Boolean 
search 
Yes Yes Yes Yes No Yes 
Structural 
search 
No Yes Yes Yes Yes Yes 
Data representation 
interface 
Medium Good Medium Excellent Good Excellent 
Additional features No No No 
Result 
statistics 
Patent 
family, IPR 
status 
Patent 
family, IPR 
status 
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3.2.3 Refining preliminary search 
3.2.3.1 Query optimization 
Virtually all of the key terms that were mentioned previously and all of their possible 
combinations are suitable for the construction of queries. However the relevance of search 
results is not equal. By relevance means how much useful patents can be extracted from the 
public patent database using this or that query. Relevance can be increased on the one hand by 
successful gathering of key terms into groups using Boolean operators and on the other hand 
by performing search into those fields of the document where density of this groups of terms 
should be maximal. 
The most successful queries were produced by combination of terms in the same group (Table 
3) with Boolean operator “OR” and gathering this “OR – tuples” with Boolean operator 
“AND”. These “OR+AND – tuples” were applied for the search within both “Abstract (Front 
page)” and “Any field” of documents at the same time using advanced search function. Three 
of the most successful ways of key terms gathering and searching fields choosing are depicted 
on the diagram below (Figure 6). 
 
Figure 6. Queries construction 
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3.2.3.2 Finding proper search class 
All patent documents that were collected during preliminary search (70 documents) were 
analyzed with the purpose to find proper patent class which can narrow down searching area. 
Main attention was given to the primary class. Primary class is the main class in which 
patents should to fall according to the opinion of experts in the patent authority.  
Results of patent analyzes is showed in Figure 7. It should be noted that almost all patent 
documents for which classes 435/6 and C12Q 1/68 are not marked like a primary classes steal 
fall into these classes like into "cross-referenced" classes. 
  
 
Figure 7. The most common primary USPC and IPC classes 
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3.3 Genotyping genetic markers of interest 
3.3.1 Main information 
The iPLEX Gold reaction kit (Figure 8) was used for genotyping (SEQUENOM, 2009). 
Short description of the steps for the iPLEX Gold assay is presented below:  
1. Isolation and amplification of the genomic DNA samples 
2. Neutralization of unincorporated dNTPs in amplification products using shrimp 
alkaline phosphatase (SAP). 
3. Performing the iPLEX Gold reaction, this involves the enzymatic addition of 
terminator nucleotides into the diagnostic site.  
4. Transfer of the iPLEX Gold reaction’s products onto a SpectroCHIP array. The 
SpectroCHIP array is then analyzed by the MassARRAY analyzer. 
 
 
 
 
 
 
  
Figure 8. The iPLEX Gold assay (SEQUENOM, 2009) 
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3.3.2 Materials and methods 
Animals 
Animals used in this study were Duroc (D) and Norwegian Landrace (L). DNA samples from 
D (86) and L (106) were extracted by BioBank AS (Hamar, Norway).  
Sequences 
Sequences for this study were obtained from the patent documents: 
 US/6,919,177 - PRKAG3 alleles and use of the same as genetic markers for 
reproductive and meat quality traits [Meat Quality, Reproduction] 
 US/6,965,022 - Methods to identify swine genetically resistant to F18 E. coli 
associated diseases [Resistance to F18 E.coli associated diseases] 
 US/7,785,778 - Porcine polymorphisms and methods for detecting them [Resistance to 
enterotoxigenic E.coli] 
 US/2004/0126795 - Genetic markers associated with scrotal hernias in pigs [Scrotal 
hernias]  
 WO/2007/084855 - Genetic markers for boar taint [Boar taint] 
Blast search was performed for each sequence. In the case when sequence from the patent 
document was not of sufficient length for genotyping or was misaligned with annotated genes 
the correspondent sequence from GeneBank was preferred. The list of the sequences and 
source information are presented in Appendix 1. 
Primers 
Primers were designed using MassARRAY Typer software (SEQUENOM, San Diego, USA) 
with 4500-8000 kDa setting for molecular mass. The successful sequences were fitted into 2 
multiplexes of 11 and 19 respectively, and used for further experiment. The list of primers 
that were used for genotyping is presented in Appendix 2. 
Solutions 
All solutions are presented in Appendix 3. 
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PCR reaction 
Materials: PCR mix, genomic DNA. 
Methods (for each of the multiplexes): PCR mix was prepared, lightly vortex and centrifuged. 
An automated liquid handling process was used for dispensing 4 μL of the PCR mix to each 
well of the multiplex. Genomic DNA (1 μL) was added to each well. Plates were vortexed 
and centrifuged at 1000 RPM. 
The samples were thermocycled as follows: 
94° C  for 15 minutes 
94° C  for 20 seconds 
56° C  for 30 seconds 
72° C  for 1 minute 
72° C  for 3 minutes 
4° C  forever 
SAP Reaction 
Materials: SAP mix. 
Methods (for each of the multiplexes): SAP mix was prepared, lightly vortexed and 
centrifuged. An automated liquid handling process was used for dispensing 2 μL of the SAP 
mix into each sample well. The sample plates were vortexed and centrifuged at 1000 RPM.  
The sample plates were incubated as follows: 
1. 37° C for 40 minutes. 
2.  85° C for 5 minutes. 
3.  4° C forever. 
  
45 cycles 
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The iPLEX Gold Reaction  
Materials: iPLEX Gold mix. 
Methods (for each of the multiplexes): The iPLEX Gold mix was prepared, lightly vortexed 
and centrifuged at 1000 RPM for one minute. An automated liquid handling process was used 
for adding 2 μL of iPLEX Gold mix to each sample well. The sample plates were vortexed 
and centrifuged at 1000 RPM. 
The samples were thermocycled as follows: 
 
Processing of the iPLEX Gold Reaction 
Materials: resin, nanopure water. 
Methods (for each of the multiplexes): Resin was transferred from its container onto the 
dimple plate using the elongated spoon and spread into the wells of the dimple plate using the 
scraper. Dimple plate with the resin stood for 20 minutes. While the resin stood in the dimple 
plate, nanopure water (16 μL) was added to the sample plate using automated liquid handling 
process. After 20 minutes, the sample plate was gently placed, upside-down, onto the dimple 
plate, so that the resin fell out of the dimple plate and into the wells of the sample plate. The 
sample plate was rotated on a rotator for five minutes at room temperature and centrifuged at 
3200 g for five minutes. 
Dispensing onto SpectroCHIP Arrays and Analyzing Spectra 
Methods (for each of the multiplexes): Nanodispensing of iPLEX Gold reaction products onto 
a SpectroCHIP array was performed using MassARRAY Nanodispenser. Assays and plates 
were set up in the MassARRAY database and spectra were acquired using the MassARRAY 
mass spectrometer. Spectra were analyzed using TyperAnalyzer Software. 
94° C  for 30 seconds 
94° C  for 5 seconds 
52° C  for 5 seconds 
80° C  for 5 seconds 
72° C  for 3 minutes 
4° C  forever 
5 cycles 
40 cycles 
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Statistical data manipulation 
Testing deviation from the HWE was performed using Pearson's chi-squared test with 1 
degree of freedom. The 5 % significance level for 1 degree of freedom is 3.84, and when the 
χ2 value was less than this, the null hypothesis that the population is in HWE was not rejected.
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4. Results 
4.1 Patents-oriented MS Access database 
The result of a MS Access patent-oriented database construction is the database itself. Since 
the database cannot be attached to the MS Word document the decision was made to present 
main structural and design features of this database in the way that each person with ordinary 
skills will be able to construct the same database from scratch or to reconstruct existing 
database. 
Figure 9 presents the data model that was used in the patent-oriented database construction. It 
is a snapshot of the standard MS Access representation of the database structure. 
The design of the main form is presented in Figure 10. This form appears at the start of the 
database, so when user double-click at the database icon, the main-form is the first thing the 
user gets to. 
Figure 11 shows how data from the patents document is presented for the database user and 
the possible ways to search for documents within internal database content.  
 
  
 
Figure 9. The data model that was used in the patent-oriented database construction 
 Figure 10. The design of the main form 
 
 Figure 11. The design of the ”Fill up and Search” form 
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4.2 Summary of patent search 
All patent documents (145 documents in total and 84 nonrecurring documents) that were 
collected during preliminary and final patent search are shown in Appendix 4. This chapter is 
aimed to summarize all information about these documents 
4.2.1 Statistical summary 
Figure 12 is presenting simple statistics for the collected documents:  
 Ranking of the documents by their IP status in Norway. 
 Ranking of the documents by their origin. For those situations where group of 
inventors from one country filed the documents jointly with inventors or/and assignees 
from other countries, these countries were combined together in single origin. 
 Issuing dynamic for the patent documents that were collected during this project 
 Ranking of the documents by the traits that are mentioned for improving. 
 Ranking of the documents by types of markers that were used in the document’s 
experimental/example part. 
 Ranking of the documents by types of breeds that were used in the document’s 
experimental/example part. 
The leader group of inventors with their assignees are listed below. 
 US + England 
 Inventors: Rothschild, Max E. (Ames, IA); Tuggle, Christopher K. (Ames, IA); Bosworth, Brad T. 
(Littleton, NC) 
 Organizations: Iowa State University Research Foundation, Inc. (Ames, IA); Pig Improvement 
Company UK Limited (GB); The United States of America as represented by the Secretary of 
Agriculture (Washington, DC); Biotechnology Research & Development Corp. (Peoria, IL) 
 Canada 
 Inventors: SQUIRES E JAMES (Guelph, CA)  
 Organizations: The University of Guelph (Guelph, CA) 
 Denmark 
 Inventors: Jorgensen; Claus Bottcher (Rahavevej 1, DK) 
 Organizations: The University of Copenhagen (Copenhagen, DK) 
 Sweden + Belgium 
 Inventors: Andersson; Leif (Uppsala, SE) 
 Organizations: Melica HB (Uppsala, SE); The University of Liege (Liege, BE); Seghersgentec 
N.V. (Buggenhout, BE) 
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Figure 12. Simple statistics for the collected documents 
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4.2.2 Structure of the claims 
All sets of claims from the patent documents that were collected during this search belong to 
the “Genes as diagnostic tools” sets of claims (Organisation for economic co-operation and 
development, 2002) (Figure 13). It should be noted that not all claims may be present in a 
single set which is dependent on the nature of the document (e.g. “test method patent”, 
“breeding methodology patent” and so on.). 
 
Figure 13. “Genes as diagnostic tools” sets of claims 
4.2.3 Broadening claim languages 
There are five general types of broadening languages that were revealed during this search, 
according to their linguistically structure: “translation language”, “hybridization language”, 
“percent identity language”, “allelic association language” and “BLAST comparison 
language”. It should be noted that one patent usually contain more than just one claim and  
inventors typically combine all these languages at once for covering as big area as possible. 
Short definition and example of each language are presented on the Figure 14. 
  
 Figure 14. Broadening languages that were revealed during patent search 
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4.2.4 Genes coverage 
Genes that were covered by the patent documents are presented in Table 5 and Table 6.  
Table 5. Genes coverage 
Genes 
Patent № Trait 
Abbreviation Full Name 
FST Follistatin US20080118914 
Litter size 
ESR Estrogen receptor 
WO/1992/018651 
US5,374,526 
EP0580767  (B1) 
US6,846,632 
US5,550,024 
PRLR Prolactin receptor 
WO/1998/003682 
EP0958376  (B1) 
US7,081,335 
US5,935,784 
RBP4 Retinol binding protein 4 
WO/2000/042218 
EP1141390  (A1) 
US5,939,264 
OPN Osteopontin 
US6,410,227 
WO/1996/041892 
EP0879296  (B1) 
FSHb Follitropin subunit beta 
US6,291,174 
US20020197597 
US20040126795 Scrotal hernias MIS Mullerian-inhibiting substance 
GPX4A Glutathione peroxidase 4a 
RAR-gamma retinoic acid receptor gamma 
US5,939,264 Reproductive traits MTNR1A melatonin receptor 1a 
VCAM-1 vascular cell adhesion molecule 1 
PRKAG3 
5'-AMP-activated protein kinase subunit 
gamma-3 
WO/2002/020850 
EP1354061  (A2) Reproductive and meat quality 
US6,919,177 
KIT Mast/stem cell growth factor receptor 
US6,849,401 
WO/1999/020795 
EP1023461  (B1) 
Coat colour 
US7,371,521 
EP1381696  (B1) 
WO/2002/086158 
US20040241676 
WO/2005/108569 
WO/1997/005278 
EP0842296  (B1) 
US6,183,955 
HSP70.2 Heat shock protein 70 
US20050112648 
Backfat thickness 
US7,435,543 
MYOG Myogenin 
WO/1997/023644 
US6,143,880 
muscle growth 
HMGA high mobility group A family 
WO/2003/078651 
EP1485504  (A2) 
Growth, fatness, meat quality, and feed 
efficiency 
US7,244,564 
H-FABP Fatty acid-binding protein 
WO/1997/035878 
EP0889904  (A2) 
Body weight 
MC4R melanocortin-4 receptor 
US6,803,190 
Fat content, weight gain, and/or feed 
consumption 
US20040261138 
US7,303,878 
WO/2001/075161 
EP1276905  (A2) 
EP1100970  (A2) 
WO/2000/006777 
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Table 6. Genes coverage (Continue) 
Genes 
Patent № Trait 
Abbreviation Full Name 
pLEPR porcine leptin receptor 
US6,458,531 
Leanness 
US20070190527 
WO/2005/017204 
EP1651777  (B1) 
AOX1 aldehyde oxidase WO/2005/030924 
EP1623004  (A2) 
Boar taint (skatole metabolism) 
 
 
CYP2A6 Cytochrome P450 2A6 
WO/2007/084855 
EP1984519  (A2) 
CYP2E1 Cytochrome P450 2E1 
3aHSD 3 alpha hydroxysteroid dehydrogenase 
3bHSD 3 beta hydroxysteroid dehydrogenase 
SULT1A1 Sulfotransferase 1A1 
CYP17A1 Cytochrome P450 17A1 
CYTB5 Cytochrome B5 WO/1998/041861 
EP0966682  (A1) 
SULT2A1 Sulfotransferase 2A1 
WO/2005/074483 
EP1737976  (A2) 
US20090221539 
EP1969126  (A1) 
WO/2007/068115 
WO/2005/123922 
EP1766025  (A1) 
US20060024708 
P450c17 LH-stimulated 17 alpha-hydroxylase WO/1999/018192 
NRAMP1 
Natural resistance-associated macrophage 
protein 
US20030129609 
Disease resistance 
US6,844,159 
WO/2002/097058 
EP1425414  (A2) 
US20040253594 
BPI Bactericidal/permeability-increasing protein 
US7,070,929 
US20040234980 
WO/2002/097136 
EP1397511  (A1) 
FUT1 alpha (1,2) fucosyltransferase 1 
US6,596,923 
Resistant to F18 E. coli associated 
diseases 
EP0985052  (B1) 
WO/1998/053102 
WO/1998/053101 
US6,965,022 
MUC4 Myogenic factor 4 US7,785,778 
Resistance to enterotoxigenic E.Coli 
(ETEC) 
MX1 Myxovirus (influenza virus) resistance 1 
US20060166188 
WO/2004/038022 
Resistance to RNA virus-origin disease 
RYR1 ryanodine receptor 
WO/1992/011387 
EP0563144  (B1) 
US5,358,649 
Malignant hyperthermia 
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4.3 Results of genotyping 
Sequences SEQ9_[SNP_81] (MIS gene) and SEQ22_[SNP_81] (SULT1A1 gene) failed 
during genotyping. Results of genotyping for successful genetic markers are presented in 
Appendix 5 and summarized in Table 7. 
Table 7. Results of genotyping 
Document № Trait SNP_ID Gene 
Information 
about 
favourable 
allele 
Hardy-Weinberg equilibrium 
Landrace Duroc 
US/6,965,022 
Resistance to 
F18 E.coli 
associated 
diseases 
SEQ3_[SNP_81] FUT1 Available Yes Yes 
WO/2007/084855 
Boar taint 
SEQ11_[SNP_83] 
CYP2E1 
Not available Yes Yes 
WO/2007/084855 SEQ12_[SNP_76] Not available Yes Yes 
WO/2007/084855 SEQ13_[SNP_81] Not available Yes Yes 
WO/2007/084855 SEQ14_[SNP_81] CYP17A1 Not available Yes Yes 
WO/2007/084855 SEQ15_[SNP_71] 
CYTB5 
Not available Yes Yes 
WO/2007/084855 SEQ16_[SNP_81] Not available Yes Yes 
WO/2007/084855 SEQ18_[SNP_81] 
3bHSD 
Not available Yes Yes 
WO/2007/084855 SEQ19_[SNP_81] Not available Yes Yes 
WO/2007/084855 SEQ20_[SNP_81] SULT1A1 Not available Yes Yes 
WO/2007/084855 SEQ24_[SNP_81] 
SULT2A1 
Not available Yes Yes 
WO/2007/084855 SEQ25_[SNP_121] Not available Yes Yes 
WO/2007/084855 SEQ11_[SNP_82] CYP2E1 Not available Yes No 
WO/2007/084855 SEQ27_[SNP_78] CYP2A6 Not available Yes No 
US/7,785,778 
Resistance to 
enterotoxigenic 
E.coli 
SEQ4_[SNP_81] 
MUC4 
Available Yes 
No 
[favourable] 
US/7,785,778 SEQ5_[SNP_81] Available Yes 
No 
[favourable] 
US/7,785,778 SEQ6_[SNP_81] Available Yes 
No 
[favourable] 
US/7,785,778 SEQ7_[SNP_81] Available Yes 
No 
[favourable] 
US/6,919,177 
Meat Quality 
Reproduction 
SEQ1_[SNP_81] 
PRKAG3 
Available 
No 
[favourable] 
Yes 
US/6,919,177 SEQ1_[SNP_146] Available 
Homozygous 
[favourable] 
Homozygous 
[favourable] 
US/6,919,177 SEQ2_[SNP_87] Available 
Homozygous 
[favourable] 
Homozygous 
[favourable] 
WO/2007/084855 
Boar taint 
SEQ21_[SNP_81] SULT1A1 Not available Homozygous Yes 
WO/2007/084855 SEQ17_[SNP_81] 3aHSD Not available Homozygous Homozygous 
WO/2007/084855 SEQ23_[SNP_81] 
SULT2A1 
Not available Homozygous Homozygous 
WO/2007/084855 SEQ25_[SNP_81] Not available Homozygous Homozygous 
WO/2007/084855 SEQ26_[SNP_81] CYP2A6 Not available Homozygous Homozygous 
US/2004/0126795 
Scrotal hernias 
SEQ8_[SNP_81] FSHb Available Yes 
No 
[unfavourable] 
US/2004/0126795 SEQ10_[SNP_81] GPX4A Available Yes 
No 
[unfavourable] 
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5. Discussion 
5.1 Last trends 
Rapid progress has been made during the last twenty years in pig gene identification, mapping 
and functional analysis. In 1993, the public databases had only gathered approximately 600 
pig sequences, while at the end of 2006, the total number of pig sequences had reached nearly 
1.3 million entries (Jiang & Rothschild, 2007). In 2003, the porcine genetic linkage map had 
nearly 3000 loci and porcine physical genetic map contained over 3000 genes and markers 
(Rothschild M. F., 2003). The current annotated swine genome assembly (Sscrofa9) was 
released in September 2009 (Archibald, et al., 2010 ). By now, Pig Quantitative Trait Locus 
(QTL) database contains 6344 pig QTLs from 281 publications (Pig QTLdb). Some of this 
information is readily used by the commercial livestock companies to improve productivity 
and consuming properties of their populations.  
The issuing dynamic that was revealed in this project allows tracing back in detail how 
actively the field of genetic markers in swine breeding has been covered by the patent 
protection during the last twenty years. From this dynamics it can be concluded that the 
interest to the IP of this field started from 1992.  
In the 1990s, two events occurred which considerably changed the focus of the researchers in 
the field of swine genetics from the laboratory work to the commercialization and patenting of 
their inventions. First and foremost was the advent of molecular biology. New DNA based 
approaches gave new opportunities for exploring the genetic differences that existed within 
the domesticated pig. This new approach was significantly more expensive and required 
larger investments than previous research. Secondly, breeding companies were becoming 
interested in DNA based selection and were willing to fund this high-risk/high-tech research. 
Perhaps the best known and largest single royalty-generating patent in animal breeding was 
filed like IPO application in 1992 (WO/1992/011387) and issued like US patent in 1994 
(US/5,358,649). This patent claims method for screening pigs (with HAL 1843™ marker) to 
determine their susceptibility to malignant hyperthermia (MH).  
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The first patent that claims use of a genetic marker for a quantitative trait (pig litter size) was 
filed like IPO application in 1992 (WO/1992/018651) and issued like US patent in 1994 
(US/5,374,526). This was also the first patent that had been exclusively assigned to one 
breeding company (Pig Improvement Company).  
These two patents became a precedent for further patenting. Consequently issuing of patents 
and patent applications was increasing from 1992 until 2005. It should be noted that the 
impact of the second patent (US/5,374,526) is not limited just by the fact that it became 
possible to get a patent on the DNA based selection method. The invention that was claimed 
in this patent was done using “candidate gene” approach1  and “major gene”2 concept for 
selecting animals on simply inherited quantitative traits. This idea was readily utilized in the 
bunch of other explorations later on. In fact almost all patents and patent applications that 
were filed until now claim inventions that were done using “candidate gene” approach and 
“major gene” concept. 
The greatest interest to the IP of genetic markers in swine was in years 2004-2005. A number 
of useful causative mutations and linked marker polymorphisms for reproduction (e.g., ESR, 
PRLR, RBP4, FSHb), feed intake and growth (e.g., MC4R), body composition (e.g., MYOG, 
H-FABP), coat colour (KIT), meat quality (e.g., HMGA, PRKAG3) and disease resistance 
(e.g., FUT1, BPI) were discovered and protected via patenting. 
After 2005 issuing of patents and patent applications became less and less frequent. This 
situation can be explained as follows: Despite that the amount of information about the swine 
genome was increasing during 2005-2010, most of the useful major genes and markers for 
economically important traits related to these genes that were not kept as a trade secret had 
been either patented or filed like a patent application until 2007. 
  
                                                 
1 “Candidate gene” approach is the approach for identification of genes that are involved in the trait’s development. This 
approach is based on preliminary data derived from studying of model objects. 
2
 “Major gene” concept is the concept that is based on the idea that some quantitative traits are mainly formed under control 
of a few genes (major) and other genes can be left out of account. 
 58 
5.2 Present situation, future trends and their consequences 
5.2.1 Present situation 
The present situation is that almost all genetic markers for simply inherited qualitative 
characteristics governed by “major genes” (e.g. porcine stress syndrome, litter size, coat 
colour, resistant to specific F18 E.coli associated diseases) have been detected and patented.  
More than 100 genetic markers for up to 35 genes and more than 80 methods for screening 
pigs with these markers were covered by the patent protection at the year 2010. All this 
information became the unique commercial asset for the livestock genetics companies. 
However, the experimental expense had limited the numbers of companies that were involved 
in the development of this field. There are five main companies that founded research and 
development in the area of swine genetic: Pig Improvement Company (PIC) UK Limited, 
HYPOR, TOPIG, DANBRED and Monsanto. Each of these companies had made their own 
decision about the way of protection for their genetic markers.  
From the analysis of the patent documents it can be seen that the biggest part of all collected 
documents (up to 60%) were filed by scientists from the University of Iowa in the US. Almost 
all Iowa’s patents are assigned to the PIC.  
The other part of the patents is preferably owned by the universities such as The University of 
Guelph (Canada), University of Copenhagen (Denmark) and University of Liege (Belgium). It 
is interesting that big companies such as HYPOR and DANBRED probably sponsored 
research groups in these universities. Nevertheless they never appear on the front page of the 
documents and no information about licensing is available in the public sector. 
PIC is the only company that made a decision to protect their intellectual assets via patenting 
until now and other big companies (i.e. HYPOR, TOPIG, DANBRED, and Monsanto) had as 
their strategy not to patent but to publish or to keep as trade secrets. 
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5.2.2 Future trends 
The “candidate gene” approach and “major gene” concept are almost played out by now. The 
main future trend will most certainly be related to shifting of research interests towards low-
heritable quantitative traits.  
The “candidate gene” approach works with only a small part of the genome and leads to 
genetic tests with only 1-5 markers for effects of major genes. This number of markers was 
enough for selection on simply inherited qualitative traits. In contrast, exploration of low-
heritable quantitative traits demands simultaneous evaluation of effects from many genes, 
each alone having an infinitely small contribution in the trait’s development. This leads to 
genetic tests with more than 100 markers. Just recently it became possible to broadly use new 
high-throughput SNP genotyping technologies for studying low-heritable quantitative traits. 
As more markers are discovered and validated by using new technology, individual marker 
effects become less and less important. Consequently using of this technology can potentially 
lead to a new field in patenting of genetic markers:  patenting of selection methods which is 
not limited to single markers but claim broad SNP profiles. However initially patent 
protection was sought for individual markers and issue of patentability for multi-markers 
systems are yet not settled. That is why in the nearest future increasing number of markers 
will most probably lead to IP of inventions via trade secret instead of patenting. 
There is one more possible trend that can appear and should be mentioned. In comparison to 
the first “deriving from the research” trend key driver for this trend came from the field of IP 
laws. 
In the 2005, Monsanto filed one PCT applications for very extensive patents on breeding 
swine (WO 2005/017204). The patents are based on simple procedures, but are incredibly 
broad in their claims. There are more than 160 countries mentioned where the patent is 
supposed to be granted. WIPO already forwarded the applications to regional patent offices. 
At this stage the patents are not yet granted, but they could be accepted for example under 
European and US regulations. If these patents will be granted, it should force other companies 
to file the same extensive patents nature of which is very different from everything that was 
granted previously.   
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5.2.3 Potential consequences for research strategy 
In General 
As soon as almost all useful genetic markers were patented it was very important to figure out 
what potential opportunities and threats these patents can provide for the research. Of course 
each patent is an independent entity which scope is determined by the claims. Some patents 
on genetic markers may have very wide coverage across species and DNA sequences while 
others may be limited to single polymorphisms in one breed. Patents may be related to a 
process, a product produced by a process or dependent on another patent. However the overall 
situation can be described as follows. 
Generally patents should promote research in the area of technology for which they belong. 
That is why patents protect but not hide technical information and some opportunities can be 
provided by patent study. 
It should be mentioned that none of the EPO patents that was collected during this project 
cover Norway, which gives a great opportunity for using these patents. However the search in 
the Norwegian patent office was not the aim of this project which means that some details can 
be missed. 
There are two opportunities if some similar patents exist in Norway. First opportunity is that 
most probably testing of these patents will fall in the term of experimental use defences. This 
provides a possibility for inventions around the patent. Second opportunity is that more than 
half of collected patents protect just methods of analysis and after precisely studying of their 
claims it can appear that using other methods will not infringe the patent.  
Despite all opportunities that can be provided by patent study, there is one very serious threat: 
even if all claims’ information were precisely analyzed, claims’ structure and nature of the 
patent were determined (e.g. “method patent”, “sequence patent”) and all arbitrary defining 
terms and broadening languages were taken into account, there is a possibility that the patent 
holder will demand litigation procedure which will lead to the litigation costs. 
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From the results of laboratory testing 
Conclusion about usefulness of the patented markers from the documents US/6,919,177; 
US/6,965,022; US/7,785,778 and US/2004/0126795 is presented in the Table 8. 
Table 8. Conclusion about usefulness of the patented markers 
 
Resistance to E.coli 
Meat Quality 
Reproduction 
Scrotal hernias 
FUT1 MUC4 PRKAG3 FSHb GPX4A 
TNA FFA AFA TNA FFA AFA TNA FFA AFA TNA FFA AFA TNA FFA AFA 
Landrace 
1 - - 4 - - 3 3 - 1 - - 1 - - 
These alleles are not fixed and can be 
useful for selection. 
Favourable alleles 
are almost fixed 
already. These 
SNPs will not be 
very useful for 
selection. 
These alleles are not fixed and can be 
useful for selection. 
D u r o c 
1 - - 4 4 - 3 2 - 1 - 1 1 - 1 
These alleles are 
not fixed and can be 
useful for selection. 
Favourable alleles are almost fixed already. 
These SNPs will not be very useful for 
selection. 
The unfavourable allele is almost fixed in 
the population. This SNP will be highly 
useful for selection. 
 
TNA - Total number of SNPs. 
FFA - Number of fixed favourable alleles of SNPs. 
AFA - Number of fixed unfavourable alleles of SNPs. 
Patent document WO/2007/084855 does not provide any information about favourable alleles 
for the patented markers. So nothing can be concluded in those situations when all animals 
were homozygote. However, most of the markers from this patent are in HWE and 
consequently are not fixed in Norsvin’s Landrace and Duroc populations. It means that these 
markers can be potentially useful for selection after additional association study.   
The legal status for each document is listed below: 
 US/7,785,778 the similar patent application was filed in Norway (Pending) but no 
patents were granted until now 
 US/6,965,022 the similar patent application was filed in Norway (Refused)  but no 
patents were granted until now 
 US/2004/0126795 (Assignment owner name - SYGEN INTERNATIONAL, 
California) no patents were granted and no patent application were filed in Norway 
until now 
 WO/2007/084855 no patents were granted and no patent application were filed in 
Norway until now 
 US/6,919,177 no similar patents and applications were found for Norway until now 
Consequently all this patent information can be most certainly used for free (but more precise 
search in Norwegian patent office is still required). 
 62 
5.2.4 Potential consequences for intellectual protection strategy 
Obtaining and maintaining patents is a form of risk management for a company. Patents 
themselves do not ensure income. They must be promoted and protected. It is very important 
to determine when expenses associated with patent protection are justified or not. For those 
situations where the cost/benefit analysis indicates that the expense of a patent protection is 
not justified, an alternative form of risk management should be sought. 
Norsvin owns no EPO or US patents and has filed no EPO or US patent applications by now. 
This seems logical because there is no direct competition in the Norwegian pig genetic 
market. Moreover, the fact that none of the EPO patents found during this project have 
designated Norway can indicate that for long period of time Norway was not seen as a market 
for big pig breeding companies. 
As it was mentioned, the era of patents for many individual markers is now gone and the issue 
of patentability for multi-markers system are yet not settled. It means that most probably the 
patents authority will require dividing a multi-markers patent into several distinct patents 
which will destroy the nature of the patent and in general will decrease the level and increase 
the cost of protection for the initial (multi-markers) invention. 
Obtaining a patent is a relatively expensive process. One can typically expect to spend at least 
$20000 per country in which protection is sought. Moreover, it is time consuming and 
generally takes more than 36 months for the genetic patents. It means that the genetic marker 
effect needs to be very large to benefit from the patent. In the case of multi-markers tests 
effect of each marker is relatively small, so it is obvious that expenses associated with patent 
protection for multi-markers tests are not justified until it will be possible to get a single 
patent with good determined scope.  
Norsvin’s present strategy of publishing instead of patenting (defensive publishing) is 
probably the best way of protecting information about genetic tests for now. The cost of 
defensive publication can be zero (e.g. conference paper) and at the same time the company 
can use that publication as a shield against threatened litigations and dangerous licensing 
campaigns. 
 63 
Conclusion  
Observing the trend of the last twenty years, it can be concluded that almost all patents and 
patent applications that were filed until now claim inventions that were done using “candidate 
gene” approach and “major gene” concept. This led to genetic tests with only 1-5 markers for 
selection on simply inherited qualitative traits.  
The “candidate gene” approach and “major gene” concept are almost played out by now. The 
present situation is that almost all genetic markers for simply inherited qualitative 
characteristics governed by “major genes” have been detected and patented.  
The main future trend will most certainly be related to shifting of research interests towards 
low-heritable quantitative traits. This leads to genetic tests with more than 100 markers, 
however issue of patentability for multi-markers system are yet not settled. Therefore, 
Norsvin’s present strategy of publishing instead of patenting is probably the best way of 
protecting information about genetic tests for now. 
None of the EPO patents that were collected during this project cover Norway, which gives a 
great opportunity for using these patents. However the search in the Norwegian patent office 
was not the aim of this project which means that some details can be missed. 
As it was shown in the results of laboratory testing, despite long-time breeding history for 
Norsvin’s L and D populations, some favourable alleles according to the claims is presented 
in a HWE. Moreover, 2 markers within the D population were not in HWE and unfavourable 
alleles according to the claims were predominant. It is indicate potential usefulness of these 
markers for selection. 
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